Poster Coauthor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Poster Coauthor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Poster Coauthor Today - Breaking & Trending Today

MyMD Pharmaceuticals, Inc.: MyMD Pharmaceuticals to Present Data on Oral TNF-a Inhibitor MYMD-1 at the British Society for Immunology (BSI) Congress 2022

Published: December 6, 2022

- Preclinical and early clinical studies of MYMD-1, an oral, small-molecule, selective TNF-a inhibitor, suggest future potential to disrupt the Rheumatoid Arthritis market - MyMD Pharmaceuticals

Source: finanznachrichten.de

Related Topics:

United KingdomAndrea CohenLeonard DunnRobert SchatzChristopher ChapmanCompany Annual Report On FormMymd PharmaceuticalsMymd Pharmaceuticals IncCompany Quarterly Reports On FormBritish Society For ImmunologySam Brown IncRheumatoid ArthritisChief Medical OfficerPoster CoauthorStatement Regarding Forward Looking StatementsAnnual ReportQuarterly Reports